124 related articles for article (PubMed ID: 7654674)
21. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.
Konstas AG; Kozobolis VP; Katsimpris IE; Boboridis K; Koukoula S; Jenkins JN; Stewart WC
Ophthalmology; 2007 Apr; 114(4):653-7. PubMed ID: 17197028
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of pilocarpine and timolol maleate combination in therapy of glaucoma].
Egorov EA; Tsibaneva EV; Egorov AE
Vestn Oftalmol; 1996; 112(3):5-7. PubMed ID: 8966866
[TBL] [Abstract][Full Text] [Related]
23. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension.
Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
Jpn J Ophthalmol; 2004; 48(3):276-80. PubMed ID: 15175922
[TBL] [Abstract][Full Text] [Related]
24. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
25. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
26. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
Brandt JD; Beiser JA; Gordon MO; Kass MA;
Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
[TBL] [Abstract][Full Text] [Related]
27. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
Tugushi OA; Shliapuzhnikova AV; Listopadova NA
Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
[No Abstract] [Full Text] [Related]
28. Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.
Nordmann JP; Berdeaux G
Clin Ther; 2007 Aug; 29(8):1751-60; discussion 1750. PubMed ID: 17919556
[TBL] [Abstract][Full Text] [Related]
29. A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
Bojić L; Mandić Z; Novak-Laus K; Sonicki Z; Karelović D
Coll Antropol; 2003 Dec; 27(2):729-34. PubMed ID: 14746165
[TBL] [Abstract][Full Text] [Related]
30. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
[TBL] [Abstract][Full Text] [Related]
31. [Initial medical treatment: beta-blockers or prostaglandins. Prostaglandins: a modern glaucoma treatment].
Baudouin C
J Fr Ophtalmol; 2004 Jun; 27(6 Pt 2):718-9. PubMed ID: 15319756
[TBL] [Abstract][Full Text] [Related]
32. Association between Glaucoma Medication Usage and Dry Eye in Taiwan.
Chen HY; Lin CL; Tsai YY; Kao CH
Optom Vis Sci; 2015 Sep; 92(9):e227-32. PubMed ID: 26192153
[TBL] [Abstract][Full Text] [Related]
33. Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.
Jayaprakasam A; Ghazi-Nouri S
Orbit; 2010 Dec; 29(6):357-9. PubMed ID: 21158579
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin postscript: a personal reflection.
Bito LZ
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S231. PubMed ID: 12204719
[TBL] [Abstract][Full Text] [Related]
35. [Experimental justification of pathogenetically directed glaucoma therapy].
Kryzhanovskiĭ GN; Kashintseva LT; Lipovetskaia EM; Kopp OP
Oftalmol Zh; 1980; 35(8):493-7. PubMed ID: 6111059
[No Abstract] [Full Text] [Related]
36. The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007.
Lin JC
J Glaucoma; 2015; 24(5):364-71. PubMed ID: 26039384
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of pilocarpine 2% and combined guanethidine 1% & adrenaline 0.5% in the treatment of chronic simple glaucoma.
Mehrotra AN; Jain BS; Anand GS
Indian J Ophthalmol; 1987; 35(3):146-8. PubMed ID: 3507410
[No Abstract] [Full Text] [Related]
38. Treatment of glaucoma by prostaglandin agonists and beta-blockers in combination directly reduces pro-fibrotic gene expression in trabecular meshwork.
Tejwani S; Machiraju P; Nair AP; Ghosh A; Das RK; Ghosh A; Sethu S
J Cell Mol Med; 2020 May; 24(9):5195-5204. PubMed ID: 32267082
[TBL] [Abstract][Full Text] [Related]
39. [Study of hypotensive effect of combined use of adrenaline and pilocarpine under experimental conditions].
Lipovetskaia EM; Kopp OP
Oftalmol Zh; 1978; 34(3):177-9. PubMed ID: 754116
[No Abstract] [Full Text] [Related]
40. [Effectiveness of treatment of primary glaucoma with prolonged-action pilocarpine].
Sporova NA; Kozlova LP; Zubareva TV; Cherkasova IN
Oftalmol Zh; 1976; 31(1):35-7. PubMed ID: 1023069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
